This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
NETSPOT: Out of Specification
Summary
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
---|---|---|---|---|---|
NETSPOT |
NETSPOT |
DIN 02490005 |
Powder For Solution, Kit |
OXODOTREOTIDE 40 MCG / VIAL |
PG19CA21001, PG19CA21002 |
Issue
The Vial 1 assay may be out of specification in the affected lot(s).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Radiopharmacy provider
Details
Advanced Accelerator Applications USA, Inc. 57 E. Willow Street, Millburn New Jersey, United States 07041
Get notified
Receive notifications for new and updated recalls and alerts by category.